Itamar Medical Ltd. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was USD 8.885 million compared to USD 7.353 million a year ago. Operating loss was USD 3.218 million compared to USD 1.743 million a year ago. Net loss was USD 3.242 million compared to USD 1.958 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago. For the half year, sales was USD 17.263 million compared to USD 13.409 million a year ago. Operating loss was USD 5.175 million compared to USD 3.038 million a year ago. Net loss was USD 5.240 million compared to USD 3.122 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.